HM781-36B
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HM781-36B, covering 2013-05-23 to 2019-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy [Phase 2]